Author

Giovanni Pellicanò

Unime - Cited by 1,350 - Malattie Infettive

Biography

Giovanni Pellicanò works at Infectious Disease Unit, University of Messina, Italy. His area of research interests includes Infectious diseases, Virology . He /she has authored of many research articles/books in the relevant scope.
Title
Cited by
Year
Physician attitudes and perceptions of complementary and alternative medicine (CAM): a Multicentre Italian study
M Berretta, L Rinaldi, R Taibi, P Tralongo, A Fulvi, V Montesarchio, ...Frontiers in oncology 10, 594, 2020202
48
2020
Transmission mode associated with coronavirus disease 2019: a review.
F Vella, P Senia, M Ceccarelli, E Vitale, H Maltezou, R Taibi, A Lleshi, ...European Review for Medical & Pharmacological Sciences 24 (14), 2020202
47
2020
Factors associated with weight gain in people treated with dolutegravir
L Taramasso, P Bonfanti, E Ricci, G Orofino, N Squillace, B Menzaghi, ...Open Forum Infectious Diseases 7 (6), ofaa195, 2020202
45
2020
The new era of vaccines: the" nanovaccinology".
A Facciolà, G Visalli, P Laganà, V La Fauci, R Squeri, GF Pellicanò, ...European Review for Medical & Pharmacological Sciences 23 (16), 2019201
40
2019
The effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on liver enzymes, glucose, and lipid profile
N Squillace, E Ricci, B Menzaghi, GV De Socio, S Passerini, C Martinelli, ...Drug Design, Development and Therapy, 5515-55,
20
2020
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection
M Ceccarelli, E Venanzi Rullo, M Berretta, B Cacopardo, GF Pellicano, ...Dermatologic Therapy 34 (1), e14660, 2021202
18
2021
The impact of DAA‐mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation …
A Bandera, P Lorenzini, L Taramasso, A Cozzi‐Lepri, G Lapadula, ...Journal of Viral Hepatitis 28 (5), 779-786, 2021202
12
2021
Durability of dolutegravir-based regimens: a 5-year prospective observational study
L Taramasso, A De Vito, ED Ricci, G Orofino, N Squillace, B Menzaghi, ...AIDS Patient Care and STDs 35 (9), 342-353, 2021202
11
2021
Hepatitis B virus infection and hepatocellular carcinoma in PLWH: Epidemiology, pathogenesis and treatment
F D’Andrea, E Venanzi Rullo, A Marino, V Moscatt, BM Celesia, ...World Cancer Res. J 7, e1537, 2020202
10
2020
Loco-regional treatments for hepatocellular carcinoma in people living with HIV
C Micali, Y Russotto, G Caci, M Ceccarelli, A Marino, BM Celesia, ...Infectious Disease Reports 14 (1), 43-55, 2022202
8
2022
Vitamin D status modulates inflammatory response in HIV+ subjects: Evidence for involvement of autophagy and TG2 expression in PBMC
M Currò, G Visalli, GF Pellicanò, N Ferlazzo, MG Costanzo, F D’Andrea, ...International Journal of Molecular Sciences 21 (20), 755, 2020202
8
2020
Epstein Barr Virus related cancer in people living with HIV: A review of the literature
F D’Andrea, E Venanzi Rullo, A Facciolà, M Di Rosa, F Condorelli, ...World Cancer Res. J , e1512, 2020202
7
2020
Thyroid diseases and thyroid asymptomatic dysfunction in people living with HIV
C Micali, Y Russotto, BM Celesia, L Santoro, A Marino, GF Pellicanò, ...Infectious Disease Reports 14 (5), 655-66, 2022202
7
2022
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)
L Taramasso, E Ricci, A Cascio, L Valsecchi, B Menzaghi, N Squillace, ...AIDS Research and Therapy 1 (1), 1-8, 2019201
6
2019
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade
L Taramasso, P Bonfanti, E Ricci, P Maggi, G Orofino, N Squillace, ...HIV medicine 23 (1), 70-79, 2022202
6
2022
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review
C Micali, Y Russotto, A Facciolà, A Marino, BM Celesia, E Pistarà, G Caci, ...Infectious Disease Reports 14 (2), 228-242, 2022202
6
2022
Editorial—Coronavirus Disease 2019 and People Living with HIV: Clinical Considerations
M Ceccarelli, G Nunnari, BM Celesia, GF Pellicanò, EV Rullo, M Berretta, ...Eur. Rev. Med. Pharm. Sci 2, 753-7539, 2020202
4
2020
Epidemiology of the new HIV infections in a large university hospital of Southern Italy: the importance of increasing the culture of the HIV screening test in the prevention of …
A Facciolà, G Visalli, G Antonuccio, F Fedele, G Nunnari, GF Pellicanò, ...Epidemiologia e Prevenzione (), 235-22, 2020202
4
2020
How much does HIV Positivity affect the presence of oral HPV? A molecular epidemiology survey
G Visalli, A Di Pietro, M Currò, M Pruiti Ciarello, F D’Andrea, G Nunnari, ...International Journal of Environmental Research and Public Health 18 (17), 8999, 2021202
3
2021
Efficacy of COVID-19 vaccination in people living with HIV: a public health fundamental tool for the protection of patients and the correct management of infection
A Facciolà, S D’Amato, S Calimeri, DL Giudice, C Micali, Y Russotto, ...Infectious Disease Reports 14 (5), 784-79, 2022202
3
2022

Referred From: https://scholar.google.com/citations?user=Pmg5X8MAAAAJ&hl=it

Cited by
Citations 1350
h-index 21
i10-index 45
Recommended Journals
Open Access Journals